• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素与一种新的核糖核苷酸还原酶抑制剂三甲曲沙联合应用对小鼠白血病的增强作用。

Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.

作者信息

Fritzer-Szekeres M, Novotny L, Romanova D, Göbl R, Sedlak J, Vachalkova A, Rauko P, Elford H L, Szekeres T

机构信息

Clinical Institute for Medical and Chemical Laboratory Diagnostics, Vienna, Austria.

出版信息

Life Sci. 1998;63(7):545-52. doi: 10.1016/s0024-3205(98)00305-1.

DOI:10.1016/s0024-3205(98)00305-1
PMID:9718080
Abstract

Ribonucleotide reductase is the rate limiting enzyme of de novo DNA synthesis; its activity is significantly increased in tumor cells related to the proliferation rate. Therefore the enzyme is considered to be an excellent target for cancer chemotherapy. In the present study we tested the in vitro and in vivo antitumor effects of a drug combination using trimidox (3,4,5-trihydroxybenzamidoxime), a novel inhibitor of ribonucleotide reductase with adriamycin, a widely used anticancer drug. This combination was selected because adriamycin generates free radicals being responsible for cardiotoxic side effects; trimidox has been shown to be a good free radical scavenger. The in vitro cytotoxic effect of the drug combination was examined in L1210 mouse leukemia cells employing a MTT chemosensitivity assay. Incubation of these cells with adriamycin and trimidox together yielded less than additive cytotoxic effects compared to either drug alone. These effects were not caused by the involvement of p-glycoprotein mediated drug efflux. However, when the effect of trimidox and adriamycin in combination was examined in L1210 leukemia bearing mice antitumor effects of adriamycin could be enhanced by the presence of trimidox. Our data indicate, that the in vivo combination of adriamycin together with trimidox might be beneficial for the treatment of malignancies.

摘要

核糖核苷酸还原酶是从头合成DNA的限速酶;其活性在与增殖速率相关的肿瘤细胞中显著增加。因此,该酶被认为是癌症化疗的一个极佳靶点。在本研究中,我们测试了一种药物组合的体外和体内抗肿瘤作用,该组合使用了新型核糖核苷酸还原酶抑制剂三甲氧苄二氨嘧啶(3,4,5-三羟基苯甲脒肟)与广泛使用的抗癌药物阿霉素。选择这种组合是因为阿霉素会产生导致心脏毒性副作用的自由基;三甲氧苄二氨嘧啶已被证明是一种良好的自由基清除剂。采用MTT化学敏感性测定法在L1210小鼠白血病细胞中检测了该药物组合的体外细胞毒性作用。与单独使用任何一种药物相比,将这些细胞与阿霉素和三甲氧苄二氨嘧啶一起孵育产生的细胞毒性作用小于相加效应。这些效应不是由P-糖蛋白介导的药物外排所导致。然而,当在荷L1210白血病小鼠中检测三甲氧苄二氨嘧啶和阿霉素联合使用的效果时,三甲氧苄二氨嘧啶的存在可增强阿霉素的抗肿瘤作用。我们的数据表明,阿霉素与三甲氧苄二氨嘧啶的体内联合使用可能对恶性肿瘤的治疗有益。

相似文献

1
Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.阿霉素与一种新的核糖核苷酸还原酶抑制剂三甲曲沙联合应用对小鼠白血病的增强作用。
Life Sci. 1998;63(7):545-52. doi: 10.1016/s0024-3205(98)00305-1.
2
Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.新型核糖核苷酸还原酶抑制剂三甲曲沙增强顺铂和环磷酰胺对荷白血病小鼠的活性。
Cancer Lett. 2006 Feb 20;233(1):178-84. doi: 10.1016/j.canlet.2005.03.013.
3
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.新型核糖核苷酸还原酶抑制剂三甲氧苄二氨嘧啶的生化及抗肿瘤活性
Cancer Chemother Pharmacol. 1994;34(1):63-6. doi: 10.1007/BF00686113.
4
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.三甲氧苄二氨嘧啶,一种核糖核苷酸还原酶抑制剂,可协同增强阿糖胞苷对HL-60人早幼粒细胞白血病细胞集落形成的抑制作用。
Biochem Pharmacol. 2002 Aug 1;64(3):481-5. doi: 10.1016/s0006-2952(02)01186-3.
5
Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.曲咪多司(3,4,5-三羟基苯甲脒肟)的铁结合能力,一种核糖核苷酸还原酶的新型抑制剂。
Eur J Clin Chem Clin Biochem. 1995 Nov;33(11):785-9. doi: 10.1515/cclm.1995.33.11.785.
6
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.三甲氧苄二氨嘧啶,一种核糖核苷酸还原酶抑制剂,可诱导HL-60早幼粒细胞白血病细胞凋亡并激活半胱天冬酶。
Exp Hematol. 2000 Aug;28(8):924-30. doi: 10.1016/s0301-472x(00)00484-7.
7
[The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].[核糖核苷酸还原酶作为新型核糖核苷酸还原酶抑制剂三甲氧苄二氨嘧啶(3,4,5-三羟基苯甲羟肟酸)酶导向化疗作用的靶点]
Wien Klin Wochenschr. 1995;107(22):694-7.
8
Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.曲阿普明(3-氨基吡啶-2-甲醛缩氨基硫脲):一种具有广谱抗肿瘤活性的核糖核苷酸还原酶活性强效抑制剂。
Biochem Pharmacol. 2000 Apr 15;59(8):983-91. doi: 10.1016/s0006-2952(99)00419-0.
9
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.替莫唑胺与核糖核苷酸还原酶抑制剂双吗啉代乙烷和三甲曲沙联合应用对恶性脑肿瘤细胞的影响
Cancer Chemother Pharmacol. 2003 Jul;52(1):41-6. doi: 10.1007/s00280-003-0611-2. Epub 2003 Apr 11.
10
Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.羟基脲和三甲氧苄二氨嘧啶增强人胰腺腺癌细胞的辐射效应。
Anticancer Res. 2000 Jan-Feb;20(1A):133-8.

引用本文的文献

1
Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?核糖核苷酸还原酶抑制剂的临床药理学与临床试验:它是一种可行的癌症治疗方法吗?
J Cancer Res Clin Oncol. 2017 Aug;143(8):1499-1529. doi: 10.1007/s00432-017-2457-8. Epub 2017 Jun 17.